Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Iridex (IRIX) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Iridex (IRIX) over the last 17 years, with Q3 2025 value amounting to $2.7 million.

  • Iridex's Other Operating Expenses rose 41.57% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.3 million, marking a year-over-year decrease of 2474.72%. This contributed to the annual value of $12.6 million for FY2024, which is 2252.88% down from last year.
  • As of Q3 2025, Iridex's Other Operating Expenses stood at $2.7 million, which was up 41.57% from $2.5 million recorded in Q2 2025.
  • Iridex's Other Operating Expenses' 5-year high stood at $5.8 million during Q1 2022, with a 5-year trough of $2.5 million in Q1 2025.
  • Over the past 5 years, Iridex's median Other Operating Expenses value was $3.8 million (recorded in 2023), while the average stood at $3.7 million.
  • In the last 5 years, Iridex's Other Operating Expenses skyrocketed by 4419.85% in 2022 and then crashed by 3453.43% in 2025.
  • Iridex's Other Operating Expenses (Quarter) stood at $3.9 million in 2021, then increased by 23.3% to $4.8 million in 2022, then dropped by 19.87% to $3.9 million in 2023, then tumbled by 30.18% to $2.7 million in 2024, then fell by 1.59% to $2.7 million in 2025.
  • Its Other Operating Expenses was $2.7 million in Q3 2025, compared to $2.5 million in Q2 2025 and $2.5 million in Q1 2025.